A detailed history of Alliancebernstein L.P. transactions in Cerus Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 189,123 shares of CERS stock, worth $353,660. This represents 0.0% of its overall portfolio holdings.

Number of Shares
189,123
Previous 189,123 -0.0%
Holding current value
$353,660
Previous $332,000 0.9%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.62 - $2.04 $22,064 - $27,784
13,620 Added 7.76%
189,123 $332,000
Q1 2024

May 14, 2024

SELL
$1.66 - $2.42 $44,107 - $64,301
-26,571 Reduced 13.15%
175,503 $331,000
Q3 2023

Nov 14, 2023

SELL
$1.5 - $3.07 $105 - $214
-70 Reduced 0.03%
202,074 $327,000
Q1 2023

May 15, 2023

BUY
$2.65 - $3.81 $13,257 - $19,061
5,003 Added 2.54%
202,144 $600,000
Q3 2022

Nov 15, 2022

BUY
$3.43 - $5.83 $18,319 - $31,138
5,341 Added 2.78%
197,141 $710,000
Q1 2022

May 13, 2022

BUY
$4.81 - $6.99 $2,885 - $4,194
600 Added 0.31%
191,800 $1.05 Million
Q3 2021

Nov 10, 2021

SELL
$4.79 - $6.68 $698,635 - $974,298
-145,853 Reduced 43.27%
191,200 $1.16 Million
Q2 2021

Jul 30, 2021

BUY
$5.35 - $6.35 $780,313 - $926,166
145,853 Added 76.28%
337,053 $1.99 Million
Q3 2020

Nov 12, 2020

SELL
$5.78 - $7.47 $31,790 - $41,085
-5,500 Reduced 2.8%
191,200 $1.2 Million
Q2 2020

Aug 13, 2020

BUY
$4.5 - $7.02 $118,800 - $185,328
26,400 Added 15.5%
196,700 $1.3 Million
Q1 2020

May 14, 2020

BUY
$2.87 - $5.49 $98,441 - $188,307
34,300 Added 25.22%
170,300 $792,000
Q1 2019

May 14, 2019

BUY
$5.16 - $6.85 $28,380 - $37,675
5,500 Added 4.21%
136,000 $847,000
Q1 2018

May 14, 2018

BUY
$3.56 - $5.74 $37,024 - $59,696
10,400 Added 8.66%
130,500 $715,000
Q4 2017

Feb 13, 2018

SELL
$2.76 - $3.95 $15,731 - $22,515
-5,700 Reduced 4.53%
120,100 $406,000
Q3 2017

Nov 13, 2017

BUY
$2.22 - $2.73 $279,276 - $343,434
125,800
125,800 $343,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $331M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.